BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30211678)

  • 1. Problem-solving breast MRI: useful or a source of new problems?
    Taşkın F; Polat Y; Erdoğdu İH; Türkdoğan FT; Öztürk VS; Özbaş S
    Diagn Interv Radiol; 2018 Sep; 24(5):255-261. PubMed ID: 30211678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be?
    Oztekin PS; Kosar PN
    Breast J; 2014; 20(6):622-31. PubMed ID: 25200378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of breast MRI as a problem-solving tool.
    Yau EJ; Gutierrez RL; DeMartini WB; Eby PR; Peacock S; Lehman CD
    Breast J; 2011; 17(3):273-80. PubMed ID: 21477168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can breast MRI accurately exclude malignancy in mammographic architectural distortion?
    Amitai Y; Scaranelo A; Menes TS; Fleming R; Kulkarni S; Ghai S; Freitas V
    Eur Radiol; 2020 May; 30(5):2751-2760. PubMed ID: 32002641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Breast MRI for Further Evaluation of Equivocal Findings on Digital Breast Tomosynthesis.
    Niell BL; Bhatt K; Dang P; Humphrey K
    AJR Am J Roentgenol; 2018 Nov; 211(5):1171-1178. PubMed ID: 30207789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Utility of Breast MRI in the Diagnosis of Malignancy After Inconclusive or Equivocal Mammographic Diagnostic Evaluation.
    Giess CS; Chikarmane SA; Sippo DA; Birdwell RL
    AJR Am J Roentgenol; 2017 Jun; 208(6):1378-1385. PubMed ID: 28267372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is breast MRI a helpful additional diagnostic test in suspicious mammographic microcalcifications?
    Baltzer PAT; Bennani-Baiti B; Stöttinger A; Bumberger A; Kapetas P; Clauser P
    Magn Reson Imaging; 2018 Feb; 46():70-74. PubMed ID: 29122667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Magnetic Resonance Mammography in the Evaluation of Indeterminate Breast Lesions.
    Mishra E; Kaur N; Kaur R; Dalal U; Handa U; Anand GS
    J Assoc Physicians India; 2023 Nov; 71(11):76-84. PubMed ID: 38720501
    [No Abstract]   [Full Text] [Related]  

  • 9. Whole-breast US following mammography and breast MRI in newly diagnosed breast cancer patients: can it be more than just a guidance tool for biopsy?
    Park YJ; Kim MJ; Moon HJ; Kim EK; Yoon JH
    Clin Radiol; 2017 May; 72(5):425.e1-425.e7. PubMed ID: 27712905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of high-risk breast lesions found on mammogram or ultrasound: the value of contrast-enhanced MRI to exclude malignancy.
    Hammersley JA; Partridge SC; Blitzer GC; Deitch S; Rahbar H
    Clin Imaging; 2018; 49():174-180. PubMed ID: 29571172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is breast MRI helpful in the evaluation of inconclusive mammographic findings?
    Moy L; Elias K; Patel V; Lee J; Babb JS; Toth HK; Mercado CL
    AJR Am J Roentgenol; 2009 Oct; 193(4):986-93. PubMed ID: 19770320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast MRI used as a problem-solving tool reliably excludes malignancy.
    Spick C; Szolar DHM; Preidler KW; Tillich M; Reittner P; Baltzer PA
    Eur J Radiol; 2015 Jan; 84(1):61-64. PubMed ID: 25454098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of Nonpalpable Breast Cancer in Premenopausal Women].
    Nudnov NV; Novikova EV
    Vestn Rentgenol Radiol; 2017; (1):5-16. PubMed ID: 30247855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review and management of breast lesions detected with breast tomosynthesis but not visible on mammography and ultrasonography.
    Taskin F; Durum Y; Soyder A; Unsal A
    Acta Radiol; 2017 Dec; 58(12):1442-1447. PubMed ID: 28530138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced spectral mammography in patients with MRI contraindications.
    Richter V; Hatterman V; Preibsch H; Bahrs SD; Hahn M; Nikolaou K; Wiesinger B
    Acta Radiol; 2018 Jul; 59(7):798-805. PubMed ID: 29058963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
    Linda A; Zuiani C; Furlan A; Lorenzon M; Londero V; Girometti R; Bazzocchi M
    AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is biopsy necessary? Role of DCE-MRI in BIRADS-3 lesions.
    Türk G; Özdemir M; Çoban M; Koç A
    Diagn Interv Radiol; 2020 Nov; 26(6):552-556. PubMed ID: 32990245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
    Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
    Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.